Key Details
Price
$0.41Annual EPS
-$4.20Annual ROE
-79.41%Beta
-Events Calendar
Next earnings date:
Jan 14, 2025Recent quarterly earnings:
Nov 15, 2021Recent annual earnings:
Mar 30, 2021Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Sept 23, 2022Analyst ratings
Recent major analysts updates
11 Aug '21 WBB Securities
Buy23 Apr '21 Maxim Group
Buy15 Mar '21 Aegis Capital
Buy17 Dec '20 Chardan Capital
Buy15 Oct '20 WBB Securities
Speculative Buy17 Sept '20 Roth Capital
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
CohBar doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Why Is CohBar (CWBR) Stock Up 130% Today?
CWBR
InvestorPlace23 May 2023
CohBar (NASDAQ: CWBR ) stock is soaring higher on Tuesday after the company announced a planned merger with Morphogenesis . CohBar and Morphogenesis are planning for an all-stock merger that will see the two combine to create a new company named “TuHURA Biosciences, Inc.” This company will continue to trade its shares on The Nasdaq Capital Market.
FAQ
- What is the primary business of CohBar?
- What is the ticker symbol for CohBar?
- Does CohBar pay dividends?
- What sector is CohBar in?
- What industry is CohBar in?
- What country is CohBar based in?
- When did CohBar go public?
- Is CohBar in the S&P 500?
- Is CohBar in the NASDAQ 100?
- Is CohBar in the Dow Jones?
- When was CohBar's last earnings report?
- When does CohBar report earnings?
- Should I buy CohBar stock now?
What is the primary business of CohBar?
CohBar, Inc. is a biotechnology company focused on developing therapies for age-related diseases. They use a unique approach by studying mitochondrial peptides, which are small proteins that can help improve health and longevity. Their goal is to create innovative treatments to enhance the quality of life as people age.
What is the ticker symbol for CohBar?
The ticker symbol for CohBar is NASDAQ:CWBR
Does CohBar pay dividends?
No, CohBar does not pay dividends
What sector is CohBar in?
CohBar is in the Healthcare sector
What industry is CohBar in?
CohBar is in the Biotechnology industry
What country is CohBar based in?
CohBar is headquartered in United States
When did CohBar go public?
CohBar's initial public offering (IPO) was on 15 December 2017
Is CohBar in the S&P 500?
No, CohBar is not included in the S&P 500 index
Is CohBar in the NASDAQ 100?
No, CohBar is not included in the NASDAQ 100 index
Is CohBar in the Dow Jones?
No, CohBar is not included in the Dow Jones index
When was CohBar's last earnings report?
CohBar's most recent earnings report was on 15 November 2021
When does CohBar report earnings?
The next expected earnings date for CohBar is 14 January 2025
Should I buy CohBar stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions